Journal article
Mutations in the mammalian target of rapamycin pathway regulators NPRL2 and NPRL3 cause focal epilepsy
MG Ricos, BL Hodgson, T Pippucci, A Saidin, YS Ong, SE Heron, L Licchetta, F Bisulli, MA Bayly, J Hughes, S Baldassari, F Palombo, M Santucci, S Meletti, SF Berkovic, G Rubboli, PQ Thomas, IE Scheffer, P Tinuper, J Geoghegan Show all
Annals of Neurology | WILEY | Published : 2016
DOI: 10.1002/ana.24547
Abstract
Objective Focal epilepsies are the most common form observed and have not generally been considered to be genetic in origin. Recently, we identified mutations in DEPDC5 as a cause of familial focal epilepsy. In this study, we investigated whether mutations in the mammalian target of rapamycin (mTOR) regulators, NPRL2 and NPRL3, also contribute to cases of focal epilepsy. Methods We used targeted capture and next-generation sequencing to analyze 404 unrelated probands with focal epilepsy. We performed exome sequencing on two families with multiple members affected with focal epilepsy and linkage analysis on one of these. Results In our cohort of 404 unrelated focal epilepsy patients, we ident..
View full abstractRelated Projects (2)
Grants
Awarded by National Health and Medical Research Council of Australia
Awarded by Telethon Foundation
Funding Acknowledgements
This work was supported by the National Health and Medical Research Council of Australia: Program Grant 628952 (to S.F.B., I.E.S., P.Q.T., and L.M.D.), Practitioner Fellowship 1006110 (to I.E.S.), Training Fellowship 1016715 (to S.E.H.), Career Development Fellowship 1032603 (to L.M.D.), a Telethon Foundation Project 13200 (to P.T. and T.P.) and a grant from the Channel 7 Children's Research Foundation (to L.M.D.).